21
Participants
Start Date
January 31, 2013
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
Imiquimod 3.75% Cream
Approximately two weeks after Day 0, the entire treatment area was treated with imiquimod 3.75% cream. Subjects utilized the 2 weeks on, 2 weeks off, 2 weeks on regimen. Subjects were followed every 2 weeks during treatment (week 2, 4 and 6) and then at 4 and 8 weeks post last-imiquimod application (week 10 and 14).
Icahn School of Medicine at Mount Sinai, New York
Bausch Health Americas, Inc.
INDUSTRY
Icahn School of Medicine at Mount Sinai
OTHER